Replies to post #33171 on OncoSec Medical Inc (ONCSQ)

[TomP1]

Archaic technology: you refer to IL12 or electroporation?

Big pharma refuses to validate: I guess that is why Merck gave us Keytruda to see if the response rate can be improved

And as for management, well you have spoken with the CEO and I remember you were pumping. Now dumping. Each to his own.

Ever since dr Pierce joined us, there is well thoughtout strategy that is being executed.

Combotrial will have interim data readout, therefore milestones are not a year await. Other trials similiar.

[TomP1]

Oh and short of cash? The runway is now 2 years long, so no they are not short of cash.